[DPHARMA] YoY Cumulative Quarter Result on 30-Jun-2009 [#2]

Announcement Date
26-Aug-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
30-Jun-2009 [#2]
Profit Trend
QoQ- 121.55%
YoY- 1.11%
Quarter Report
View:
Show?
Cumulative Result
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Revenue 70,412 68,329 64,777 61,728 60,977 55,804 54,907 4.22%
PBT 17,906 17,166 16,582 20,337 20,630 21,334 20,917 -2.55%
Tax -4,331 -4,310 -4,146 -4,877 -5,339 -5,842 -5,546 -4.03%
NP 13,575 12,856 12,436 15,460 15,291 15,492 15,371 -2.04%
-
NP to SH 13,575 12,856 12,436 15,460 15,291 15,492 15,371 -2.04%
-
Tax Rate 24.19% 25.11% 25.00% 23.98% 25.88% 27.38% 26.51% -
Total Cost 56,837 55,473 52,341 46,268 45,686 40,312 39,536 6.23%
-
Net Worth 162,400 154,105 140,182 136,003 129,043 145,758 139,356 2.58%
Dividend
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Div 4,858 4,859 6,245 83 11,100 - 9,754 -10.95%
Div Payout % 35.79% 37.80% 50.22% 0.54% 72.60% - 63.46% -
Equity
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Net Worth 162,400 154,105 140,182 136,003 129,043 145,758 139,356 2.58%
NOSH 138,803 138,833 138,794 138,779 138,756 138,817 139,356 -0.06%
Ratio Analysis
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
NP Margin 19.28% 18.81% 19.20% 25.05% 25.08% 27.76% 27.99% -
ROE 8.36% 8.34% 8.87% 11.37% 11.85% 10.63% 11.03% -
Per Share
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
RPS 50.73 49.22 46.67 44.48 43.95 40.20 39.40 4.29%
EPS 9.78 9.26 8.96 11.14 11.02 11.16 11.03 -1.98%
DPS 3.50 3.50 4.50 0.06 8.00 0.00 7.00 -10.90%
NAPS 1.17 1.11 1.01 0.98 0.93 1.05 1.00 2.64%
Adjusted Per Share Value based on latest NOSH - 138,837
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
RPS 7.31 7.10 6.73 6.41 6.33 5.80 5.70 4.22%
EPS 1.41 1.34 1.29 1.61 1.59 1.61 1.60 -2.08%
DPS 0.50 0.50 0.65 0.01 1.15 0.00 1.01 -11.04%
NAPS 0.1687 0.1601 0.1456 0.1413 0.1341 0.1514 0.1448 2.57%
Price Multiplier on Financial Quarter End Date
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Date 29/06/12 30/06/11 30/06/10 30/06/09 30/06/08 29/06/07 30/06/06 -
Price 2.23 2.34 2.45 2.13 2.48 2.64 2.69 -
P/RPS 4.40 4.75 5.25 4.79 5.64 6.57 6.83 -7.06%
P/EPS 22.80 25.27 27.34 19.12 22.50 23.66 24.39 -1.11%
EY 4.39 3.96 3.66 5.23 4.44 4.23 4.10 1.14%
DY 1.57 1.50 1.84 0.03 3.23 0.00 2.60 -8.05%
P/NAPS 1.91 2.11 2.43 2.17 2.67 2.51 2.69 -5.54%
Price Multiplier on Announcement Date
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Date 16/08/12 18/08/11 24/08/10 26/08/09 26/08/08 23/08/07 23/08/06 -
Price 2.38 2.22 2.45 2.50 2.30 2.70 2.77 -
P/RPS 4.69 4.51 5.25 5.62 5.23 6.72 7.03 -6.51%
P/EPS 24.34 23.97 27.34 22.44 20.87 24.19 25.11 -0.51%
EY 4.11 4.17 3.66 4.46 4.79 4.13 3.98 0.53%
DY 1.47 1.58 1.84 0.02 3.48 0.00 2.53 -8.64%
P/NAPS 2.03 2.00 2.43 2.55 2.47 2.57 2.77 -5.04%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment